This restaurant chain specializing in salads is primed to surge nearly 50%, Oppenheimer says
The firm reiterated an outperform rating on the restaurant chain stock and listed it as a top pick.
Source link
- Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly’s weight loss drug dominance
- Police break up pro-Palestine protests at Berlin, Amsterdam campuses
